...
首页> 外文期刊>The American journal of geriatric pharmacotherapy >A review of laxative therapies for treatment of chronic constipation in older adults.
【24h】

A review of laxative therapies for treatment of chronic constipation in older adults.

机译:泻药治疗老年人慢性便秘的综述。

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Multiple studies have addressed the treatment of chronic constipation in adults in general; however, less guidance is available for treating this condition in older patients. Objective: The aim of this paper was to review the effectiveness of laxatives for chronic constipation in the elderly. Methods: Medline, Web of Science, international Pharmaceutical Abstracts, and the Cochrane database of Systematic Reviews were searched for english-language articles evaluating the treatment of chronic constipation in older individuals from the inception of the databases until October 2010. Search terms included constipation, treatment, laxative, elderly, and geriatric. Articles were excluded if the mean age was <65 years. Results: Thirty-one trials were identified. These studies varied widely in terms of methodology, quality, sample size, efficacy end points, and duration. Mean stool frequency was 9.08 bowel movements per week with psyllium and 8.29 per week with calcium polycarbophil (P = 0.04). docusate sodium daily, docusate sodium q12h, and docusate calcium daily for 3 weeks produced a mean stool frequency of 1.95 bowel movements per week versus 1.50 for placebo (P = NS), 2.29 versus 1.76 (P = NS), and 2.83 versus 1.75 (P<0.02), respectively. Mean stool frequency with lactulose versus placebo was 0.7 and 0.5 bowel movements per day (P<0.02). in patients receiving polyethylene glycol or lactulose, mean stool frequency was 1.3 and 0.9 bowel movements per day (P = 0.005). in a study comparing senna plus a bulking agent with lactulose, mean stool frequency was 4.5 per week for the combination product versus 2.2 per week for lactulose (P<0.001). A study comparing sodium picosulfate with senna reported a mean stool frequency of 0.71 and 0.63 per day (P value not reported). Lubiprostone was associated with 5.69 spontaneous bowel movements per week versus 3.46 per week for placebo (P = 0.001). Conclusions: Higher-quality trials evaluating the treatment of constipation in older patients are needed to create a basis for more definitive recommendations in this population. The approach to older adults with constipation should be individualized.
机译:背景:多项研究普遍针对成人慢性便秘的治疗。但是,在老年患者中治疗这种疾病的指导较少。目的:本文旨在回顾泻药对老年人慢性便秘的有效性。方法:从数据库开始到2010年10月,搜索Medline,Web of Science,国际药物文摘和Cochrane系统评价数据库,以评估评估老年人慢性便秘治疗的英语文章。搜索词包括便秘,治疗,通便,老人和老年病。如果平均年龄小于65岁,则排除文章。结果:确定了31个试验。这些研究在方法论,质量,样本量,功效终点和持续时间方面差异很大。车前草的平均大便次数为每周9.08排便,聚卡波非钙的每周平均大便次数为8.29(P = 0.04)。每天3周服用docusate钠,q12h服用docusate钠和3周每天服用docusate钙,平均大便频率为每周1.95排便,而安慰剂为1.50(P = NS),2.29对1.76(P = NS),2.83对1.75( P <0.02)。乳果糖对安慰剂的平均大便频率为每天排便0.7和0.5(P <0.02)。在接受聚乙二醇或乳果糖的患者中,平均大便频率为每天排便1.3和0.9(P = 0.005)。在一项将番泻叶加填充剂与乳果糖进行比较的研究中,联合产品的平均大便次数为每周4.5次,而乳果糖为2.2次每周(P <0.001)。一项将去甲基硫酸钠与番泻叶进行比较的研究报告,平均大便频率为每天0.71和0.63(未报告P值)。鲁比前列酮每周有5.69次自发排便,而安慰剂每周有3.46次(P = 0.001)。结论:需要进行更高质量的评估老年患者便秘治疗的试验,以为该人群中更明确的建议奠定基础。便秘的老年人的治疗方法应个体化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号